CJC-1295 + Ipamorelin blend: research, legal status and who sells it
This page is information, not medical advice. CJC-1295 + Ipamorelin blend is not approved as a medicine in the markets below unless stated. We don't publish dosing or usage instructions.
- Also known as
- CJC-1295 and ipamorelin blend
- Category
- Blend of two unapproved growth hormone secretagogues
- Evidence level
- Early human trials
- Price range
- $1.75/mg to $12.00/mg, median $5.20/mg across 47 vendors (compare)
- Our lab tests
- None yet (how testing will work)
Legal and regulatory status
| Where | Status |
|---|---|
| United States | Neither CJC-1295 nor ipamorelin is FDA-approved, and no approved product combines them [1]. |
| United Kingdom | No UK-licensed medicine contains either peptide [2][3]. |
| European Union | No medicine containing CJC-1295 or ipamorelin is authorized in the EU, according to EMA's central and Article 57 product data [4][5]. |
| Canada | No product containing CJC-1295 or ipamorelin appears in Health Canada's Drug Product Database [6]. |
| Australia | Both CJC-1295 and ipamorelin are Schedule 4 with Appendix D possession controls [7]. |
| Sport (WADA) | Both components are prohibited at all times under S2 [8]. |
We haven't published a full overview of CJC-1295 + Ipamorelin blend yet. The legal status table and live prices on this page are current.
CJC-1295 + Ipamorelin blend prices: cheapest listings
The five lowest $/mg listings out of 74. See all CJC-1295 + Ipamorelin blend prices
| Vendor | Transparency | Product | Size | Price | $/mg | Stock | Vendor's page |
|---|---|---|---|---|---|---|---|
| Bulk Peptide Wholesale | 45 | CJC-1295 Ipamorelin 5 mg/ 5 mg (10 vials) | 10 mg × 10 | $175 | $1.75/mg | View | |
| Nexaph | 45 | CJC-no DAC / Ipamorelin Blend – 5mg/5mg (10 vials/kit) | 10 mg × 10 | $198 | $1.98/mg | View | |
| Bulk Peptide Supply | 57 | CJC-1295 Ipamorelin 5 mg/ 5 mg | 10 mg | $20 | $2.00/mg | View | |
| Crush Research | 10 | CJC-1295 (No DAC)/Ipamorelin Blend 5/5mg | 10 mg × 10 | $249 | $2.49/mg | View | |
| S1 Research | 50 | CJC-ND 5mg +IPA 5mg | 10 mg | $27 | $2.70/mg | View |
Sources
- Drugs@FDA: FDA-Approved Drugs (database searched by active ingredient). U.S. Food and Drug Administration. Accessed Oct 14, 2026
- MHRA Products: licensed-medicine search for "cjc-1295". Medicines and Healthcare products Regulatory Agency (UK). Accessed Oct 14, 2026
- MHRA Products: licensed-medicine search for "ipamorelin". Medicines and Healthcare products Regulatory Agency (UK). Accessed Oct 14, 2026
- EMA medicines data: centrally authorised human medicines (export of 14 October 2026). European Medicines Agency. Accessed Oct 14, 2026
- EMA Article 57 product data: medicines authorised in the EU/EEA (data as of 9 October 2026). European Medicines Agency. Accessed Oct 14, 2026
- Drug Product Database online query (searched by active ingredient). Health Canada. Accessed Oct 14, 2026
- Therapeutic Goods (Poisons Standard—October 2026) Instrument 2026 (F2026L01327, registered 30 September 2026). Federal Register of Legislation, Australian Government. Accessed Oct 14, 2026
- World Anti-Doping Code International Standard: Prohibited List 2026 (in force 1 January 2026). World Anti-Doping Agency. Accessed Oct 14, 2026